Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.
Recently, Next Generation Sequencing (NGS) has begun to supplant other technologies for gene mutation testing that is now required for targeted therapies. However, transfer of NGS technology to clinical daily practice requires validation.We validated the Ion Torrent AmpliSeq Colon and Lung cancer pa...
Main Authors: | Nicky D'Haene, Marie Le Mercier, Nancy De Nève, Oriane Blanchard, Mélanie Delaunoy, Hakim El Housni, Barbara Dessars, Pierre Heimann, Myriam Remmelink, Pieter Demetter, Sabine Tejpar, Isabelle Salmon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4569137?pdf=render |
Similar Items
-
Design and Validation of a Gene-Targeted, Next-Generation Sequencing Panel for Routine Diagnosis in Gliomas
by: Nicky D’Haene, et al.
Published: (2019-06-01) -
Clinical Application of Targeted Next Generation Sequencing for Colorectal Cancers
by: Quitterie Fontanges, et al.
Published: (2016-12-01) -
Complete Response to Afatinib of an EGFR Exon 18 delE709_T710insD-Mutated Stage IV Lung Adenocarcinoma
by: Blandine Jelli, et al.
Published: (2021-08-01) -
Implication des galectines-1 et -3 dans l'angiogenèse et en particulier en ce qui concerne les lymphomes
by: D'Haene, Nicky
Published: (2011) -
PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium
by: Lucie Bienfait, et al.
Published: (2018-01-01)